Lopez-Beltran A, Croghan G A, Croghan I, Matilla A, Gaeta J F
Unit of Anatomical Pathology, University of Cordoba, Spain.
Am J Clin Pathol. 1994 Jul;102(1):109-14. doi: 10.1093/ajcp/102.1.109.
Pathologic grade and stage, immunohistochemical analysis of eight cell and tumor markers, and DNA ploidy were studied in 36 cases of bladder cancer to determine the features of value in assessment of patients' survival. Tumors of high grade and advanced stage correlated with DNA aneuploidy, whereas low grade and early stage correlated with DNA diploidy when simultaneously evaluated with survival. In addition, blood group isoantigen A correlated with DNA ploidy in deceased patients, whereas blood group isoantigen H and oncogene-related protein p21 correlated with DNA ploidy in surviving patients. Despite the relatively small number of cases studied, these results suggest that pathologic grade and stage and immunohistochemical analysis of blood group isoantigens A and H and oncogene-related protein p21 hold additional value in the prediction of bladder cancer survival when evaluated simultaneously with DNA ploidy.
对36例膀胱癌患者进行了病理分级和分期、8种细胞和肿瘤标志物的免疫组化分析以及DNA倍体研究,以确定评估患者生存价值的特征。当与生存率同时评估时,高级别和晚期肿瘤与DNA非整倍体相关,而低级别和早期肿瘤与DNA二倍体相关。此外,血型同种抗原A在已故患者中与DNA倍体相关,而血型同种抗原H和癌基因相关蛋白p21在存活患者中与DNA倍体相关。尽管研究的病例数量相对较少,但这些结果表明,当与DNA倍体同时评估时,病理分级和分期以及血型同种抗原A和H以及癌基因相关蛋白p21的免疫组化分析在预测膀胱癌生存方面具有额外价值。